Clinical Trial Update: Collection of Bone Marrow From Donors Treated With or Without Filgrastim [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating collection of bone marrow from donors treated with or without filgrastim; completed with results posted in 2020.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Healthy Stem Cell Donor Disease-free Status

Drugs mentioned

• Filgrastim (filgrastim)

Snippet

Sponsor: Children's Oncology Group | Conditions: Healthy Stem Cell Donor, No Evidence of Disease | Phase 3 | Status: COMPLETED | Results posted: 2020-02-26